N-(4-METHOXYPHENYL)-6-METHYL-4-PYRIMIDINAMINE, 95.0%, 500mg

ETHYL 3-(4-CHLOROBENZYL)PIPERIDINE-3-CARBOXYLATE HCL, 95.0%, 100mg

4-Bromo-2-(bromomethyl)thiophene, 95+%, 5g

1-Bromo-2-nitronaphthalene, 95%, 1g

4-Methoxyphenyl 2,6-Bis-O-(4-methylbenzoyl)-beta-D-galactopyranoside>98.0%(HPLC)1g

(S)-1-(4-(Dimethylamino)-3-methylbenzyl)-5-(2,2-diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid compound with 2,2,2-trifluoroacetic acid (1:2), 98%, 5mg

1-(Pyridazin-4-yl)ethanamine, 95.0%, 250mg

5-Methoxy-1H-indole-2-carbaldehyde, 97%, 500mg

4'-carboethoxy-3-(2-methylphenyl)propiophenone, 97.0%, 1g

1-tert-Butyl 3-ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1,3(2H)-dicarboxylate, 95.0%, 5g

tert-butyl ((1R,3S)-3-acetylcyclopentyl)carbamate compound with tert-butyl ((1S,3R)-3-acetylcyclopentyl)carbamate, 97%, 500mg

2-(4-Bromo-2-chlorophenyl)acetic acid, 95.0%, 10g

4-Bromo-2-methylthiophene, 95.0%, 25g